Bank of the West’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
DSA
Bank of the West's DGX Position: Q1 2022 in Review
Bank of the West sold out of Quest Diagnostics (DGX) in Q1 2022, closing a stake of 2,336 shares — an estimated $404K sold.
Bank of the West first reported a position in DGX in Q3 2021 and held it in 2 quarters. The position peaked at $404K in Q4 2021. 852 funds tracked by Wall St. Rank hold DGX as of Q1 2022.
- Bank of the West reported no remaining Quest Diagnostics position as of Q1 2022 after selling out during the quarter.
- Bank of the West sold 2,336 Quest Diagnostics shares in Q1 2022, an estimated $404K.
- Bank of the West first reported a position in Quest Diagnostics in Q3 2021 and held it in 2 quarters.
- Bank of the West's Quest Diagnostics position peaked at $404K in Q4 2021.
- 852 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2022.
Based on Bank of the West's 13F filing for Q1 2022, filed 22 Apr 2022.